ArticleNeurobiology of stress2025
Electroacupuncture attenuates anxiety caused by chronic mild stress through inhibiting NOX2-derived oxidative stress in ventral hippocampus.
Article in Neurobiology of stress, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Restoration of Excitation-Inhibition Balance and Improvement of Schizophrenia-like Behavioral Deficits via Electroacupuncture.CNS neuroscience & therapeutics · 2026Article
- Acupuncture Modulates Neurotransmitter-Related Molecules in the Amygdala to Ameliorate Generalized Anxiety Disorder.CNS neuroscience & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anxiety disorders are highly prevalent and often triggered or worsened by chronic stress, yet current pharmacological treatments have limitations. Electroacupuncture (EA), a modern adaptation of traditional acupuncture, has shown promise as an alternative therapy for anxiety, though its mechanisms remain unclear. In this study, we investigated whether EA can alleviate anxiety-like behaviors induced by chronic mild stress (CMS) in mice, focusing on the role of NOX2-mediated oxidative stress and synaptic function in the ventral hippocampus. CMS exposure led to increased anxiety-like behavior, enhanced excitatory synaptic transmission, and elevated oxidative stress specifically in the ventral CA1 (vCA1) region. EA treatment was associated with normalization of excitatory/inhibitory synaptic balance and reduction in oxidative stress markers and NOX2 expression. Furthermore, overexpression of NOX2 in vCA1 induced anxiety-like behaviors, which EA partially ameliorated. These findings suggest that EA's anxiolytic effects may involve NOX2-related oxidative stress pathways and hippocampal excitability modulation, providing mechanistic insights that warrant further investigation for potential therapeutic applications (Graphical Abstract).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.